LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic licensing Dermira has a track record of licensing deals and acquisitions, including an exclusive license with Evommune and a full acquisition by Eli Lilly. This indicates openness to partnering for development programs and potential co-development or licensing opportunities for inflammatory dermatology assets.

Inflammatory program focus Recent activity centers on three inflammatory disease programs and a portfolio related to chronic inflammation. This suggests a sales opportunity to engage with Izzy or Lilly-backed ventures and Dermira-managed assets for adjunctive therapies or companion diagnostics in inflammatory dermatology.

Product distribution shifts QBREXZA cloth launch and subsequent sale of related assets to Journey Medical indicate a strategic realignment of dermatology products. This presents a chance to explore distribution partnerships, licensing of new topical therapies, or accretive channel collaborations in U.S. pediatrics and adults.

Financial readiness With significant funding history and a substantial acquisition price by Eli Lilly, the company demonstrates strong financial backing for development programs. BD teams can position collaborative deals that leverage Dermira’s R&D pipeline and secure co-development or milestone-based licensing.

Clinical and physician engagement Dermira emphasizes understanding patient and physician needs and bridging unmet skin biology insights. This alignment suggests opportunities to propose value-based partnerships, KOL-led studies, and real-world evidence collaborations to accelerate adoption of new dermatology therapies.

Similar companies to Dermira, Inc.

Dermira, Inc. Tech Stack

Dermira, Inc. uses 8 technology products and services including Drupal, WordPress, Twemoji, and more. Explore Dermira, Inc.'s tech stack below.

  • Drupal
    Content Management System
  • WordPress
    Content Management System
  • Twemoji
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Mustache
    Javascript Frameworks
  • New Relic
    Real User Monitoring
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics

Media & News

Dermira, Inc.'s Email Address Formats

Dermira, Inc. uses at least 3 email formats:
Dermira, Inc. Email FormatsExamplePercentage
First.Last@dermira.comJohn.Doe@dermira.com
93%
First@dermira.comJohn@dermira.com
6%
First.MiddleLast@dermira.comJohn.MichaelDoe@dermira.com
1%

Frequently Asked Questions

What is Dermira, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Dermira, Inc.'s main corporate office by phone at
+1-650-421-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dermira, Inc.'s official website and social media links?

Minus sign iconPlus sign iconDermira, Inc.'s official website is dermira.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Dermira, Inc. generate?

Minus sign iconPlus sign icon As of November 2026, Dermira, Inc.'s annual revenue is estimated to be $25M - $50M.

What is Dermira, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign iconDermira, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dermira, Inc. have currently?

Minus sign iconPlus sign iconAs of November 2026, Dermira, Inc. has approximately 19 employees across 2 continents, including North America and Europe. Key team members include Chief Scientific Affairs Officer: D. A., Vice President Investor Relations: I. C. and Head Of Talent Acquisition: D. R. Explore Dermira, Inc.'s employee directory with LeadIQ.

What industry does Dermira, Inc. belong to?

Minus sign iconPlus sign iconDermira, Inc. operates in the Biotechnology Research industry.

What technology does Dermira, Inc. use?

Minus sign iconPlus sign iconDermira, Inc.'s tech stack includes Drupal, WordPress, Twemoji, Google Cloud, Mustache, New Relic, MediaElement.js and Google Analytics.

What is Dermira, Inc.'s email format?

Minus sign iconPlus sign iconDermira, Inc.'s email format typically follows the pattern of First.Last@dermira.com. Find more Dermira, Inc. email formats with LeadIQ.

How much funding has Dermira, Inc. raised to date?

Minus sign iconPlus sign icon As of November 2026, Dermira, Inc. has raised $1.1B in funding. The last funding round occurred on Mar 19, 2019 for $150M.

When was Dermira, Inc. founded?

Minus sign iconPlus sign iconDermira, Inc. was founded in 2010.
Dermira, Inc. logo

Dermira, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Dermira, Inc. is a biotechnology research company focused on medical dermatology, aiming to translate advances in skin biology into new therapies for chronic skin conditions. Based in Menlo Park, California, the organization emphasizes understanding patient and physician needs to identify and develop clinical programs that address unmet dermatology treatment gaps. The company positions itself as a bridge between scientific innovation in skin biology and practical, differentiated therapies for inflammatory and other dermatological diseases. Dermira operates within the biopharmaceutical sector, with a user base spanning patients affected by chronic skin conditions and dermatology clinicians who treat them. The firm’s activities are oriented toward advancing clinical programs that reflect patient and physician needs, contributing to developments in medical dermatology through its research and development efforts.

Section iconCompany Overview

Phone number
+1-650-421-****
Website
dermira.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1.1B

    Dermira, Inc. has raised a total of $1.1B of funding over 13 rounds. Their latest funding round was raised on Mar 19, 2019 in the amount of $150M as a Post IPO Equity.

  • $25M - $50M

    Dermira, Inc.'s revenue is estimated to be in the range of $25M - $50M

Company Leadership

  • Chief Scientific Affairs Officer at Dermira, Inc.
    D. A.
    Chief Scientific Affairs Officer
    Mobile Phone
  • Vice President Investor Relations at Dermira, Inc.
    I. C.
    Vice President Investor Relations
    Mobile Phone
  • Head Of Talent Acquisition at Dermira, Inc.
    D. R.
    Head Of Talent Acquisition
    Mobile Phone
  • Executive Assistant To Chief Financial Officer at Dermira, Inc.
    L. P.
    Executive Assistant To Chief Financial Officer
    Mobile Phone
  • Senior Director Head Of Corporate Communications at Dermira, Inc.
    E. J.
    Senior Director Head Of Corporate Communications
    Mobile Phone

Employee Directory

  • Vice President Investor Relations at Dermira, Inc.
    I. C.
    Vice President Investor Relations
    Mobile Phone
  • Senior Vice President Quality at Dermira, Inc.
    R. B.
    Senior Vice President Quality
    Mobile Phone
  • Senior Director, Manufacturing And Supply Chain at Dermira, Inc.
    M. P.
    Senior Director, Manufacturing And Supply Chain
    Mobile Phone
  • Senior Director Alliance And Project Management at Dermira, Inc.
    A. C.
    Senior Director Alliance And Project Management
    Mobile Phone
  • Executive Director, Professional Relations at Dermira, Inc.
    D. S.
    Executive Director, Professional Relations
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.